Expression of urokinase-type plasminogen activator (uPA) and vascular endothelial growth factor (VEGF) in esophageal cancer and their influence to tumor angiogenesis
- Author:
- No author available
- Journal Title:
- CANCER RESEARCH AND CLINIC
- Issue:
- 6
- DOI:
- 10.3760/cma.j.issn.1006-9801.2011.06.004
- Key Word:
- 尿纤溶酶原激活物;血管内皮生长因子类;食管肿瘤;新生血管化,病理性;免疫组织化学;Urinary plasminogen activator;Vascular endothelial growth factors;Esophageal neoplasms;Neovascularization,pathologic;Immunohistochemistry
Abstract： Objective To investigate the expression and influence to tumor angiogenesis of urokinase-type plasminogen activator (uPA) and vascular endothelial growth factor (VEGF) in esophageal carcinoma. Methods The expression of uPA and VEGF in the tissue of normal (18 cases) and esophageal carcinoma (68 cases) were evaluated by SP immunohistochemistry, CD34 was detected as marking tumor microvessel density (MVD). uPA and VEGF expression were assessed as to the pathologically biological features of esophageal cancer and to the influence to tumor angiogenesis. Results The positive rates of uPA were 27.8 % (5/18) and 70.6 % (48/68) in the tissue of normal and esophageal carcinoma, respectively, there was significant difference in two tissues (x2 =11.63, P <0.05). The positive rates of VEGF were 22.2 % (4/18)and 63.2 % (43/68) in the tissue of normal and esophageal carcinoma, respectively, there was significant difference in two eissues (x2 =9.78, P <0.05). The expressions of uPA and VEGF in esophageal carcinoma were uniformity (x2 =9.72, P <0.05). The mean of MVD was 42.38±11.62. The positive rates of uPA and VEGF were higher in the high MVD group than those in the low MVD group (x2 =6.13, P <0.05, x2 =10.12, P <0.05,respectively). uPA and VEGF expressions in malignant tumors weren' t associated with age, gender and pathological types (P >0.05), but associated with clinical stage, histologic grading and lymph node metastasis (P <0.05). Conclusion Rising expression levels of uPA and VEGF are common in esophageal carcinoma. Altered expression of uPA and VEGF may contribute to tumor angiogenesis of esophageal carcinoma, whose overexpression indicate worse prognosis.
- [1]秦蓉,盛霞,吴继锋,等.胃癌组织中uPA系统及VEGF表达与侵袭转移的关系[J].2005,(6).
- [2]康志强,姜斌,李平,等.尿激酶型纤溶酶原激活物在非小细胞肺癌组织中的表达[J].2003,(8).
- [3]张玉阳,帅茨霞,郑飞云.尿激酶型纤溶酶原激活物在卵巢上皮性癌组织中的表达与受体及临床预后的关系[J].2007,(8).
- [4]肖继平,张莉,齐云,等.uPA及VEGF在乳腺癌中的表达及意义[J].2007,(1).
- [5]江波,张灿珍,赵金奇,等.血管内皮生长因子在非小细胞肺癌中的表达及临床相关性研究[J].2007,(12).
- [6]Qing-Xue Zhang,Christopher J. Magovern,Charles A. Mack,etc.Vascular Endothelial Growth Factor Is the Major Angiogenic Factor in Omentum: Mechanism of the Omentum-Mediated Angiogenesis[J].1997,67(2).
- [7]Wilhelm O,Reuning U,Ulm K,etc.Clinical impact of the plasminogen activation system in tumor invasion and metastasis: prognostic relevance and target for therapy.[J].1997,78(1).
- [8]Katoh M,Katoh Y.Comparative integromics on VEGF family members.[J].2006,28(6).
- [9]Botkjaer KA,Kupriyanova TA,Conn EM.Comparative analysis of metastasis variants derived from human prostate carcinoma cells: roles in intravasation of VEGF-mediated angiogenesis and uPA-mediated invasion.[J].2009,175(4).
- [10]Pepper MS,Tenan M,Montesano R,etc.Response of bovine endothelial cells to FGF-2 and VEGF is dependent on their site of origin: Relevance to the regulation of angiogenesis.[J].2001,82(4).
- [11]Mazar AP.Urokinase plasminogen activator receptor choreographs multiple ligand interactions: implications for tumor progression and therapy.[J].2008,14(18).
- [12]Ute Reuning,Viktor Magdolen,Sandra Hapke,etc.Molecular and Functional Interdependence of the Urokinase-Type Plasminogen Activator System with Integrins[J].2003,384(8).
- [13]Acerbi G,Parenti G,Gasperi M,etc.Microvascular density and vascular endothelial growth factor expression in normal pituitary tissue and pituitary adenomas.[J].2003,26(1).
- [14]Iseki Kazushige,Tatsuta Masaharu,Uehara Hiroyuki,etc.Inhibition of angiogenesis as a mechanism for inhibition by L\u03b1\u2010hydroxyvitamin D3 and 1,25\u2010dihydroxyvitamin D3 of colon carcinogenesis induced by azoxymethane in Wistar rats[J].1999.